Risk-benefit assessment is the comparison of the risk of a situation to its related benefits, i.e. a comparison of scenarios estimating the overall health impact. The risk–benefit analysis paradigm mirrors the classical risk analysis one: risk–benefit assessment goes hand-in-hand with risk–benefit management and risk–benefit communication. The various health effects associated with food consumption, together wi...
Fish and other seafood are important sources of nutrients, but they are also sources of chemical contaminants that may cause adverse health effects. This article aimed to identify existing risk–benefit assessments (RBA) of fish, shellfish, and other seafood, compare methodologies, discuss differences and commonalities in findings, and identify limitations and ways forward for future studies. We conducted a scop...
State of the art. Data from a recent Portuguese national project that studied the toxic effects of children exposure (under 3 years old) to multiple mycotoxins in infant foods (MYCOMIX) reported the co-occurrence of 21 mycotoxins and metabolites present in breakfast cereals primarily marketed for children. This study showed that 96% of the analyzed breakfast cereal samples were contaminated with mycotoxins1,2. ...
RiskBenefit4EU – Partnering to strengthen the risk–benefit assessment within EU using a holistic approach, is a recent European pilot project funded by EFSA and coordinated by Portugal (PT), integrating a multidisciplinary team from health and food institutes, national food safety authorities, R&D institutions and academia from PT, Denmark (DK) and France (FR). The main objectives of RiskBenefit4EU concerns the...
Over the last years, the contamination of different foodstuffs with multiple mycotoxins has been highly reported. Data from a recent Portuguese national project that studied the toxic effects of exposure of children under 3 years old to multiple mycotoxins in infant foods (MYCOMIX) reported the co-occurrence of twenty-one mycotoxins and metabolites present in breakfast cereals primarily marketed for children. T...